FB
Fortress Biotech, Inc.
FBIO · NASDAQ
$2.46 -0.81% (-$0.02)
1M -15.46%
Market Cap $81.7M
P/E Ratio 0.73x
Div. Yield -
ROE 103.52%
Piotroski F-Score Moderate
6/9Valuation
100 /100
Cheap P/E 0.73x
P/FCF 0.65x
P/S 1.19x
Growth
13 /100
Declining Rev. growth 5.83%
Book val. growth 6.13%
EPS growth N/A
Profitability
70 /100
Strong Gross margin 62.53%
FCF margin 183.80%
Net margin 163.32%
Quality
48 /100
Average ROIC 10.85%
Asset turnover 0.22x
ROE 103.52%
Debt
98 /100
Low Debt/Equity 0.39x
Net debt/EBITDA -0.82x
Current ratio 3.96x
Stability
53 /100
Moderate Beta 1.19x
Profitable years 1
Rev. volatility 24.49%
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o FBIO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Lindsay A. Rosenwald
Employees
78
Headquarters
Bay Harbor Islands
Nadchodzące wydarzenia
16 LIS
Earnings
Upcoming earnings report